Press release


12/04/2013
Althia receives ENAC Accreditation for its technical competence and diagnostic laboratory in Pathology and Molecular Pathology
The National Accreditation Body (ENAC) has granted accreditation to Althia Health, SL (Althia) in recognition of the quality and technical competence according to the criteria in the UNE-EN ISO 15189:2007, for testing of Pathology and Molecular Pathology.
 
Althia is the first accredited laboratory in Spain in accordance with the UNE-EN ISO 15189 in immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). The scope of such clearance is for the determination of HER2 protein overexpression by immunohistochemistry (IQ) and HER2 gene amplification by FISH in breast cancer tissue.

Overexpression of HER2 is crucial to evaluate prior to treatment if certain antitumor drugs are effective or not, mainly in breast and gastric cancers. More information about HER2 in Althia’s website (www.althia.es)

Accreditation UNE-EN ISO 15189 ensures, unlike the ISO 9001 certification for quality management, technical expertise and management as a laboratory or technical entity.

With this accreditation, Althia confirms its commitment to the highest levels of service quality diagnostic care, services and research collaborations, as well as in the field of clinical trials. The goal is to keep working to expand the scope of accreditation obtained
 
Documentación:
 
Related links:
 
 
Permalink  
 
Developed by Web4Bio